Supplementary References from Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK<sup>+</sup> Tumors

crossref(2023)

引用 0|浏览15
暂无评分
摘要

Supplementary References

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要